Skinive accuracy 2021 report “Dynamics of the neural network accuracy in the context of modernization of the algorithms of skin pathology recognition” is officially published at Social Science Research Network.
Skinive neural network uses a machine-learning algorithm to calculate the risk rating of skin pathologies. For this study, we used Skinive’s 2020 and 2021 versions trained on 64,000 and 115,000 images respectively. We used three validation datasets to assess the sensitivity of the algorithm. Each dataset contains 285 images: precancer + cancer, HPV skin pathology, acne. We also calculated specificity on a separate validation set containing 6,000 benign neoplasm cases.
The purpose of this study was to estimate the accuracy of Skinive algorithm in 2021.
We have improved the algorithm to show a statistically significant decrease in the number of neural network errors in determining the risks of skin pathologies.
As a result, sensitivity and specificity of the Skinive neural network indicate that the algorithm is highly accurate in detecting various neoplasms and skin diseases. The sensitivity of the Skinive neural network in detecting malignant neoplasms was 89.1% and 95.4% in 2020 and 2021 respectively. The specificity of Skinive’s neural network in determining benign neoplasms was 95.3% in 2020 and 97.9% in 2021.
In conclusion, for all skin neoplasms: in 2020, the sensitivity was 95.3%, for specificity 93.5%. By comparison, In 2021, it was 97.9% and 97.1% respectively.
Recommended articles preview:
28th September 2021
Skinive reviews: what do doctors think of the Skinive MD app? Survey of the first users.
Skinive MD became available on Appstore and Google Play in May 2021. Over 3 months of summer, more than 3000 users from the CIS countries and Europe took part in the open testing of the application and left Skinive reviews. Interesting fact: according to statistics, 8 out of 10 people make their choice based on […]
14th December 2018
Skin Cancer Self-examinations: Understand Your Risks
“Discovering a skin cancer early can make the difference…between life and death.” The difference between life and death…” Wow. As frightening as that might be, never underestimate the power that comes with knowing the techniques for early detection. Remember, skin cancer is almost always curable — if it’s detected and removed early. Knowing the facts enables early […]
29th April 2022
Skinive visiting Digital Medical Expertise & Applications Exhibition (DMEA’22), Berlin
Skinive visiting DMEA – Europe’s leading digital health event with around 11,000 visitors, more than 500 exhibitors and 300 speakers from Germany and abroad. DMEA (Digital Medical Expertise & Applications Exhibition) is Europe’s leading event for the digitalization of healthcare. The focus on the Berlin Exhibition Grounds was on the digital transformation of the healthcare […]